These results jointly indicated that ATO-induced downregulation of the increased Mcl-1 level in venetoclax-treated KG1 and KG1a cells could occur via similar mechanisms to those employed in ATO-treated APL cells. Here, MCL1 is linked to acute promyelocytic leukemia.